Valeo Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-120
| Closed | -$35K | – | 716 |
|
|
2021
Q1 | $35K | Buy |
+120
| New | +$35K | ﹤0.01% | 945 |
|
|
2020
Q3 | – | Sell |
-121
| Closed | -$21K | – | 1644 |
|
|
2020
Q2 | $21K | Buy |
121
+50
| +70% | +$8.68K | ﹤0.01% | 982 |
|
|
2020
Q1 | $10K | Sell |
71
-170
| -71% | -$23.9K | ﹤0.01% | 1040 |
|
|
2019
Q4 | $37K | Buy |
241
+170
| +239% | +$26.1K | ﹤0.01% | 740 |
|
|
2019
Q3 | $9K | Sell |
71
-1
| -1% | -$127 | ﹤0.01% | 1032 |
|
|
2019
Q2 | $10K | Hold |
72
| – | – | ﹤0.01% | 1013 |
|
|
2019
Q1 | $10K | Hold |
72
| – | – | ﹤0.01% | 952 |
|
|
2018
Q4 | $8K | Sell |
72
-42
| -37% | -$4.67K | ﹤0.01% | 927 |
|
|
2018
Q3 | $14K | Sell |
114
-2
| -2% | -$246 | ﹤0.01% | 856 |
|
|
2018
Q2 | $14K | Sell |
116
-21
| -15% | -$2.53K | ﹤0.01% | 854 |
|
|
2018
Q1 | $15K | Buy |
137
+65
| +90% | +$7.12K | ﹤0.01% | 806 |
|
|
2017
Q4 | $8K | Sell |
72
-2
| -3% | -$222 | ﹤0.01% | 869 |
|
|
2017
Q3 | $8K | Buy |
+74
| New | +$8K | ﹤0.01% | 744 |
|